Neuros Medical Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
43
- Latest Deal Type
-
General Corporate Purpose
- Latest Deal Amount
-
$35M
- Investors
-
29
Neuros Medical General Information
Description
Developer of neuromodulation technology designed to develop proprietary therapies for unmet needs in patients worldwide. The company's technology delivers a high-frequency electrical signal to sensory nerves in the peripheral nervous system to block the pain signal and helps in the treatment of chronic pain in a variety of applications, including post-amputation pain, chronic post-surgical pain, and chronic migraine, enabling patients to get relief from pain at an affordable price.
Contact Information
Website
www.neurosmedical.comCorporate Office
- 26800 Aliso Viejo Parkway
- Suite 250
- Aliso Viejo, CA 92656
- United States
Corporate Office
- 26800 Aliso Viejo Parkway
- Suite 250
- Aliso Viejo, CA 92656
- United States
Neuros Medical Timeline
Neuros Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 15. General Corporate Purpose | 10-Mar-2026 | $35M | Completed | Generating Revenue | ||
| 14. Debt - General | 11-Dec-2025 | Completed | Generating Revenue | |||
| 13. Later Stage VC (Series D) | 09-Jul-2025 | Completed | Generating Revenue | |||
| 12. Later Stage VC (Series C) | 01-Nov-2023 | Completed | Generating Revenue | |||
| 11. Mezzanine | 10-Aug-2023 | Completed | Generating Revenue | |||
| 10. Secondary Transaction - Private | 01-Aug-2022 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series BB) | 07-Jan-2021 | Completed | Generating Revenue | |||
| 8. Debt - PPP | 01-May-2020 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series AA) | 22-Oct-2019 | $2.39M | $36.3M | Completed | Generating Revenue | |
| 6. Later Stage VC (Series AA) | 03-Aug-2017 | $22.6M | $33.9M | Completed | Generating Revenue |
Neuros Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | ||||||||
| Class D-1 NV | ||||||||
| Series C | ||||||||
| Series BB | 78,686,449 | $0.000100 | $0.03 | $0.58 | $0.58 | 1x | $0.58 | 15.34% |
| Series AA | 53,285,514 | $0.000100 | $0.03 | $0.58 | $0.58 | 1x | $0.58 | 10.39% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Neuros Medical Comparisons
Industry
Financing
Details
Neuros Medical Competitors (20)
One of Neuros Medical’s 20 competitors is Mainstay Medical, a Venture Capital-Backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Mainstay Medical | Venture Capital-Backed | San Diego, CA | ||||
| Saluda Medical | Formerly PE-Backed | Bloomington, MN | ||||
| Theranica | Venture Capital-Backed | Netanya, Israel | ||||
| Nevro | Formerly VC-backed | Redwood City, CA | ||||
| Spark Biomedical | Venture Capital-Backed | Dallas, TX |
Neuros Medical Patents
Neuros Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4605069-A2 | Apparatuses and methods for setting an electrical dose | Pending | 19-Oct-2022 | ||
| EP-4605069-A4 | Apparatuses and methods for setting an electrical dose | Pending | 19-Oct-2022 | ||
| US-20260166321-A1 | Apparatuses and methods for setting an electrical dose | Pending | 19-Oct-2022 | ||
| WO-2024086757-A2 | Apparatuses and methods for setting an electrical dose | Inactive | 19-Oct-2022 | ||
| WO-2024086757-A3 | Apparatuses and methods for setting an electrical dose | Inactive | 19-Oct-2022 | A61N1/36071 |
Neuros Medical Signals
Neuros Medical Investors (29)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BF Belmont | Family Office | Minority | ||
| EQT Life Sciences | Venture Capital | Minority | ||
| JobsOhio Ventures | Venture Capital | Minority | ||
| Trinity Capital (Phoenix) | Asset Manager | Minority | ||
| Amzak Health | Venture Capital | Minority |
Neuros Medical FAQs
-
When was Neuros Medical founded?
Neuros Medical was founded in 2008.
-
Where is Neuros Medical headquartered?
Neuros Medical is headquartered in Aliso Viejo, CA.
-
What is the size of Neuros Medical?
Neuros Medical has 43 total employees.
-
What industry is Neuros Medical in?
Neuros Medical’s primary industry is Therapeutic Devices.
-
Is Neuros Medical a private or public company?
Neuros Medical is a Private company.
-
What is Neuros Medical’s current revenue?
The current revenue for Neuros Medical is .
-
How much funding has Neuros Medical raised over time?
Neuros Medical has raised $226M.
-
Who are Neuros Medical’s investors?
BF Belmont, EQT Life Sciences, JobsOhio Ventures, Trinity Capital (Phoenix), and Amzak Health are 5 of 29 investors who have invested in Neuros Medical.
-
Who are Neuros Medical’s competitors?
Mainstay Medical, Saluda Medical, Theranica, Nevro, and Spark Biomedical are some of the 20 competitors of Neuros Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process